WAVE LOGO NEW COLOR SWOOSH.jpg
Wave Life Sciences Reports Third Quarter 2021 Financial Results and Provides Business Update
November 10, 2021 07:30 ET | Wave Life Sciences USA, Inc.
Strengthened balance sheet with approximately $52 million; focusing additional investment in RNA editing programs led by hepatic editing Optimized AIMers for AATD program demonstrate potent, highly...
WAVE LOGO NEW COLOR SWOOSH.jpg
Wave Life Sciences to Present at the Stifel 2021 Virtual Healthcare Conference
November 08, 2021 16:05 ET | Wave Life Sciences USA, Inc.
CAMBRIDGE, Mass., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people...
WAVE LOGO NEW COLOR SWOOSH.jpg
Wave Life Sciences Announces Initiation of Dosing in Phase 1b/2a Clinical Trial of WVE-N531 in Duchenne Muscular Dystrophy
September 29, 2021 08:30 ET | Wave Life Sciences USA, Inc.
Trial is expected to enroll 15 boys with DMD amenable to exon 53 skipping First systemically administered therapeutic candidate with PN backbone chemistry modifications to be assessed in the clinic ...
WAVE LOGO NEW COLOR SWOOSH.jpg
Wave Life Sciences Announces New Data for Leading RNA Editing Capability Across Multiple Tissues and Provides Update on AATD Program During Analyst and Investor Research Webcast
September 28, 2021 16:05 ET | Wave Life Sciences USA, Inc.
Durable ADAR editing in vivo in preclinical models, including in CNS tissues with editing out to at least four months Chemistry optimization yields a four-fold increase over PBS control in AAT...
WAVE LOGO NEW COLOR SWOOSH.jpg
Wave Life Sciences to Present at the Chardan Virtual Genetic Medicines Conference
September 22, 2021 16:05 ET | Wave Life Sciences USA, Inc.
CAMBRIDGE, Mass., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people...
D2L logo.png
D2L INTRODUCES D2L WAVE—THE FUTURE OF UPSKILLING AND RESKILLING
July 07, 2021 09:52 ET | D2L
Kitchener, Waterloo, July 07, 2021 (GLOBE NEWSWIRE) -- Global learning technology leader D2L today announced the launch of D2L Wave, a bold new approach to professional development that makes it...
WAVE LOGO NEW COLOR SWOOSH.jpg
Wave Life Sciences to Present at Jefferies Virtual Healthcare Conference
May 28, 2021 08:30 ET | Wave Life Sciences USA, Inc.
CAMBRIDGE, Mass., May 28, 2021 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people...
WAVE LOGO NEW COLOR SWOOSH.jpg
Wave Life Sciences to Present at RBC Capital Markets Global Healthcare Virtual Conference
May 10, 2021 16:05 ET | Wave Life Sciences USA, Inc.
CAMBRIDGE, Mass., May 10, 2021 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people...
Ideanomics.jpg
Ideanomics Featured in Syndicated Broadcast Covering Definitive Agreement to Acquire Leading Provider of Wireless Charging Systems for Commercial EVs
January 11, 2021 09:00 ET | Ideanomics
NEW YORK, Jan. 11, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Ideanomics (NASDAQ: IDEX) today announces that it has been featured in a broadcast via NetworkNewsAudio (NNA), a solution that delivers...
Selligent Marketing Cloud Named a Leader in Cross-Channel Campaign Management by Leading Independent Analyst Firm
November 19, 2019 11:12 ET | Selligent Marketing Cloud
SAN JOSE, Calif., Nov. 19, 2019 (GLOBE NEWSWIRE) -- Selligent Marketing Cloud (Selligent), the intelligent marketing and customer experience cloud platform, today announced that the company has been...